A new role of SGLT-2 - treatment of IgA-nephropathy?
Sodium Glucose co-transporter 2 inhibitors (SGLT2) paved their way into traditional science books less than a decade ago as a new class of drugs treating diabetes. However, the ongoing discovery of their ever-widening array of uses shows that we are still yet to tap into their full potential. SGLT2...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-12-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/7076 |